Revolutionary new peanut allergy treatment received FDA approval
Fewed by - Muzammil Zafar
The Federal Drug Administration has approved, for the first time, a treatment developed by biopharmaceutical company Aimmune Therapeutics from California, which has shown tremendous promise in alleviating peanut allergies in children and adolescents, with almost two-thirds of 372 children showing tolerance for the small amounts of peanut protein in two peanuts.
california
tolerance
drug
company
protein
peanut
allergy
aimmune
therapeutics
approve
fda
Wed Feb 05
-
ScienceNews